Filter Results:
(134)
Show Results For
- All HBS Web
(586)
- People (4)
- News (134)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (172)
Show Results For
- All HBS Web
(586)
- People (4)
- News (134)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (172)
Sort by
- 01 Aug 2001
- News
Cleveland Global Alumni Conference a Sold-Out Success
investment in math and physical sciences. Moving on to challenges Merck has faced, Gilmartin explained that new drug discovery tools have increased the speed at which its competitors can introduce new products to the marketplace, even as... View Details
- 07 Oct 2014
- News
Network Effect
was shocked by their advice. “They said, ‘Try three Advil a day. It might help. There are a few FDA-approved drugs for Alzheimer’s disease, and they won’t help,’” he recalls. McCance, a venture- capital pioneer with Greylock Partners, had... View Details
Keywords: Linda Kush
- 01 Jan 2009
- News
Kathryn E. Giusti, MBA 1985
aided in the development of drugs for this and other cancers. A successful marketing executive who had worked at Merck, Gillette, and Searle, Giusti was diagnosed with myeloma in 1996. As she faced a grim... View Details
- 01 Jun 2000
- News
The Business of Biotech
"blockbusters" will disappear. Recent developments suggest that doctors will eventually be able to treat patients more effectively with medicine tailored to their genetic makeup, including, in some cases, gene replacement therapies. "The... View Details
Keywords: Julia Hanna
- 01 Sep 2011
- News
Alumni Team Up to Fight Cancer
networking among its alumni community. Bowes, founding partner of US Venture Partners, and Giusti, founder of the Multiple Myeloma Research Foundation (MMRF), discussed the need for innovative, results-oriented biomedical research and View Details
- 25 Apr 2014
- News
A revolution in healing
Stéphane Bancel (MBA 2000) is president and CEO of Moderna Therapeutics, which is producing a new drug application that could revolutionize the biotech world. It hinges on messenger RNA, or mRNA, the molecules responsible for transporting... View Details
- 05 May 2020
- News
“Walking a Tightrope”
Kristof, most of which have focused on poverty in developing countries. But in the Pulitzer Prize-winning duo’s latest book, Tightrope: Americans Reaching for Hope, they turn their lens on working class communities in the United... View Details
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
The blind man depicted in the sculpture suffers from river blindness, a disease that ravaged countless lives in the developing world until Merck researchers discovered the breakthrough drug Mectizan. The... View Details
- 04 Sep 2019
- News
Deep Dive
manage a worldwide team to develop a virtual product—diving to the bottom of all five oceans, and doing a lot of science along the way.” The Five Deeps Expedition, Vescovo said, has “proven to be as challenging as any business thing I’ve... View Details
- 01 Sep 2017
- News
Ink: Miami’s Dark Neon Era, the Language of Success, and Getting Psyched Up
and two other amazing, true stories NEW Hotel Scarface by Roben Farzad “There’s so much unresolved about Miami’s cocaine coming-of-age. I found the address where the Cold War crashed into the war on drugs crashed into the cocaine wars... View Details
- 01 Mar 2010
- News
Noted & Quoted
“Unfortunately, the technology for growing flu viruses to make vaccines is fifty years old — it’s chicken eggs.” — HBS Professor of Management Practice and former Merck CEO Raymond Gilmartin, at a November HBS panel discussion on drug... View Details
- 01 Jun 2018
- News
Floor It
leading from the street to the house itself. That insight, coupled with the radical nature of precision medicine, led to a realization: A “business as usual” approach wouldn’t do the trick; a different way of fighting cancer required an equally innovative approach to... View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- 01 Jan 2003
- News
Daniel L. Vasella, M.D.
quickly," he observes. Under his guidance, Novartis has been a leader not only in developing new drugs but in making them accessible to those in need around the globe. Dan Vasella has experienced first-hand... View Details
- 04 Sep 2019
- News
Accelerating Scientific Discovery
development of a course that could enhance decision making by providing participants with the knowledge and skills to better manage, fund, and commercialize scientific discoveries that could potentially cure illnesses ranging from... View Details
Keywords: Jennifer Gillespie
- 01 Jun 2018
- News
The Long Run
trajectory of overdose deaths from prescription drugs and heroin. According to the Centers for Disease Control and Prevention, the US death rate from opioid overdose has increased over 400 percent since 1999; the picture is even grimmer... View Details
- 25 Aug 2014
- News
Wendell P. Weeks, MBA 1987
brink of failure through a painful restructuring and commitment to both innovation and the diversification of its product lines. “We make products that change the world,” he says, noting Corning’s development of LCD glass; tools to... View Details
Keywords: Susan Young
- 01 Jun 2012
- News
Inspiration Is Not Enough
animated screen stars for decades of royalty income. IKEA founder Ingvar Kamprad developed a rigorous vendor-screening process that, though not sexy, provided the furniture retailer with “an impressive supply chain that is virtually... View Details
- 01 Mar 2017
- News
How Deep Brain Stimulation Could Change Medicine
developed at Minnesota’s Mayo Clinic. Kevin Bennet (MBA 1980) chairs the hospital’s 102-year-old engineering department, where some of the first machines designed to keep patients alive during open-heart surgery were developed. Today,... View Details
Keywords: Janelle Nanos
- 24 Apr 2014
- News
Finding a cure so that others may benefit
call. The foundation wanted to invest in for-profit bioscience companies to spur scientists to find a cure for the disease. O’Donnell is credited with almost singlehandedly raising $250 million in support of this venture philanthropy, which led to the View Details
- 24 Apr 2014
- News
Building a better India through business and philanthropy
more than 30 countries, Mumbai-based Piramal Group comprises companies focused on health care, life sciences, drug discovery, health care information management, financial services, specialty-glass packaging, and real estate. Recently,... View Details